Sofosbuvir and daclatasvir dual regimen cures most people with HCV genotypes 1, 2, or 3

A 12-week, once-daily regimen of the hepatitis C polymerase inhibitor sofosbuvir and the NS5A inhibitor daclatasvir, without interferon or ribavirin, produced sustained virological response rates for treatment-naive people in the 90 to 100% range, and appeared effective regardless of HCV subtype, IL28B host gene pattern or use of ribavirin, ... (more)

[Axel]

Thank's all doctor and voluntar pacient

[Margaret Dudley]

This is the most significant drug development in the history of Hepatitis C. Two drugs that cured across three genotypes WITHOUT Ribavirin or Interferon! Why is the entire world not outraged by Gilead's refusal to make this life-saving drug combination available? If this were the cure for cancer would the response be different? This IS the cure for Hepatitis C, a disease that now kills more people than AIDS. HCV is now the leading reason for liver transplants! Sign petition at www.HepC-Cured.org and add your name to this growing effort. We must stand up and be heard or we will never see this cure!

The HCV Coalition for The Cure